OP
GSK icon

ORG Partners’s GSK GSK Stock Holding History

ORG Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$20.5K Sell
418
-110
-21% -$5.13K ﹤0.01% 797
2025
Q3 		$22.8K Hold
528
– – ﹤0.01% 767
2025
Q2 		$20.6K Sell
528
-55
-9% -$2.1K ﹤0.01% 753
2025
Q1 		$22.1K Buy
583
+50
+9% +$1.83K 0.01% 664
2024
Q4 		$18K Buy
533
+322
+153% +$11.6K ﹤0.01% 769
2024
Q3 		$8.63K Sell
211
-1,400
-87% -$57.3K ﹤0.01% 812
2024
Q2 		$61.8K Buy
1,611
+1,400
+664% +$58.9K 0.01% 738
2024
Q1 		$8.95K Buy
+211
New +$8.7K 0.02% 295
2023
Q4 		– Sell
-137
Closed -$4.97K – 1227
2023
Q3 		$4.97K Hold
137
– – ﹤0.01% 954
2023
Q2 		$4.83K Buy
+137
New +$4.91K ﹤0.01% 1077

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ORG Partners's GSK Position: Q4 2025 in Review

ORG Partners reduced its GSK (GSK) stake by 21% in Q4 2025, selling an estimated $5.13K and leaving 418 shares worth $20.5K. The position accounts for ﹤0.01% of the portfolio, ranked #797.

ORG Partners first reported a position in GSK in Q2 2023 and has held it in 10 quarters since. The position peaked at $61.8K in Q2 2024. 995 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • ORG Partners held 418 shares of GSK worth $20.5K as of Q4 2025.
  • ORG Partners sold 110 GSK shares in Q4 2025, an estimated $5.13K.
  • GSK made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #797 holding.
  • ORG Partners first reported a position in GSK in Q2 2023 and has held it in 10 quarters since.
  • ORG Partners's GSK position peaked at $61.8K in Q2 2024.
  • 995 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.